Evidence map›Paper›PMID 35234509›Full record

ArticleMicrobiology spectrum2022

Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of

Yuzhen Xu, Qingluan Yang, Jingyu Zhou, Feiran Zhou, Yufan Hezhang, Yan Gao, Lingyun Shao, Jichan Shi, Qiaoling Ruan, Wenhong Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yuzhen Xu *Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospitalgrid.411405.5, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Qingluan Yang *Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospitalgrid.411405.5, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Jingyu Zhou *Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospitalgrid.411405.5, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Feiran Zhou *Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospitalgrid.411405.5, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Yufan HezhangDepartment of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospitalgrid.411405.5, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Yan GaoDepartment of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospitalgrid.411405.5, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Lingyun ShaoDepartment of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospitalgrid.411405.5, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Jichan ShiDepartments of Infectious Disease, Wenzhou Central Hospital, the Dingli Clinical Institute of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Qiaoling RuanDepartment of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospitalgrid.411405.5, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.ORCID 0000-0003-4931-3510
Wenhong ZhangDepartment of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospitalgrid.411405.5, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Fudan University · CNShanghai Medical College of Fudan University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

QuantiFERON-TB Gold Plus (QFT-Plus) is an emerging QuantiFERON test after QuantiFERON-TB Gold In-Tube (QFT-GIT) for tuberculosis infection detection; it is an IFN-γ release assay. We compared QFTPlus, which has an additional TB antigen 2 (TB2) tube to induce cell-mediated (CD8

Indexed as

Latent TuberculosisMycobacterium tuberculosisTuberculosisHumansImmunocompromised HostImmunosuppressive AgentsInterferon-gamma Release TestsTuberculin TestImmunosuppressive Agentsimmunocompetent patientsimmunocompromised patientsQFT-GITQFT-Plustuberculosis

Identifiers

PMID35234509
PMCPMC9045206
OpenAlexW4214805838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.